Consultants are being incentivised to prescribe cheaper drugs under a scheme where their hospital can keep some of the savings. Consultants are being incentivised to prescribe cheaper drugs under a scheme where their hospital can keep some of the savings. HSE chief Paul Reid said the hospital consultants were being urged to prescribe biosimilar drugs, which are more cost-effective than branded medicines, where possible. It works in the same way and is a form of hospital treatment for long-term medical conditions including rheumatoid arthritis, Crohn's disease and psoriasis. Mr Reid was outlining measures which are being taken by the HSE to reduce its deficit.

Source: Irish Independent October 03, 2019 01:30 UTC